Evaluation of the pharmacodynamics, pharmacokinetics and safety of repeated escalating oral doses of S 38844 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction A phase II, randomised, double-blind, parallel-group, placebo controlled, international multicentre study.

Trial Profile

Evaluation of the pharmacodynamics, pharmacokinetics and safety of repeated escalating oral doses of S 38844 versus placebo in patients with chronic heart failure and left ventricular systolic dysfunction A phase II, randomised, double-blind, parallel-group, placebo controlled, international multicentre study.

Completed
Phase of Trial: Phase II

Latest Information Update: 25 Aug 2015

At a glance

  • Drugs S 38844 (Primary)
  • Indications Chronic heart failure; Left ventricular dysfunction
  • Focus Pharmacodynamics
  • Sponsors IRIS
  • Most Recent Events

    • 11 Jul 2015 Status changed from recruiting to completed, according to European Clinical Trials Database record.
    • 16 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top